Study suggests age divide in cost-effectiveness of IVF treatment options
(PhysOrg.com) -- The findings of a study led by the University of Aberdeen could put IVF treatment 'on a more equal footing' with chronic diseases when it comes to making decisions about the cost effectiveness of treatment options.
The team, which included researchers from the University of Oxford, NHS Glasgow, Birmingham Womens Fertility Centre, and Aberdeen Maternity Hospital, used data from 6135 women from three Scottish Centres to model the costs and consequences of single and double embryo transfer in women of different ages.
The results indicate that single embryo transfer is likely to be preferred in most women under 37. However in older women who have a lower chance of pregnancy, including twin pregnancy, double embryo transfer may be considered cost-effective.
The team also conducted an analysis to assess how cost-effectiveness would change if women were to be allowed access to publicly funded treatment aged 40 years and above the current cut off point for IVF treatment on the NHS.
The Human Embryology and Fertilisation Authority (HEFA) which regulates IVF in the UK advocates the use of single embryo transfer as a way of reducing twin births associated with IVF and recommends a national target of a twin birth rate below 10 per cent.
Twin pregnancies are associated with increased maternal and neonatal complications, as well as long-term child disability, and the additional care required increases costs to the health service.
However, women are often deterred from taking up single embryo transfer fearing it will reduce their chances of conceiving or result in the need for additional treatment cycles.
The authors of the study, published in the British Journal for Obstetrics and Gynaecology, hope their findings will be considered by policy makers when it comes to making decisions about IVF treatment options.
Mr Graham Scotland, from the University of Aberdeen Health Economics Research Unit, led the study. He said: No other economic analysis has looked at a strategy of single versus double embryo transfer over multiple cycles in women of different ages. Our results generally support a strategy of single embryo transfer in women aged 36 or under, but as women get older the additional cost per extra live birth with double embryo transfer decreases.
No guidance exists on how much society should be willing to pay for a successful birth so we estimated the impact of the alternative numbers of embryos transferred on womens quality of life using quality-adjusted life years (QALYs), an approach which is used to assess the value for money of interventions in other areas of health care.
The researchers found that the additional cost per extra QALY for double versus single embryo transfer decreased with womens age because of the lower probability of twin pregnancy and associated complications with double embryo transfer in older women.
Under NICE guidelines in the UK, interventions that cost below £20,000 to £30,000 per additional QALY are often considered cost-effective.
Mr Scotland added: Applying this threshold range, single embryo transfer would be more likely to be considered cost-effective for women under 37 years.
For women aged 3739 years, the decision over embryo transfer may best be considered on a case-by-case basis, though our model suggests that double embryo transfer will have a higher likelihood of being considered cost-effective for older women within in this age range.
For women aged 40 and over double embryo transfer may offer the most efficient approach to IVF.
Provided by University of Aberdeen
- Elective single embryo transfer boosts the chance of a healthy baby Dec 22, 2010 | not rated yet | 0
- Single embryo implants work better: study Mar 25, 2009 | not rated yet | 0
- New strategy could reduce twin rate after IVF Sep 30, 2010 | not rated yet | 0
- 3 IVF attempts double chances Nov 09, 2009 | not rated yet | 0
- Size of a woman's uterus can predict whether she is at risk of having very premature twins after IVF Jul 09, 2008 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
How can there be a term called "intestinal metaplasia" of stomach
18 hours ago Hello everyone, Ok Stomach's normal epithelium is simple columnar, now in intestinal type of adenocarcinoma of stomach it undergoes "intestinal...
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013 From pressure-volume curve of the lung and chest wall (attached photo), I don't understand why would the elastic recoil pressure of the lung is...
If you became brain-dead, would you want them to pull the plug?
May 17, 2013 I'd want the rest of me to stay alive. Sure it's a lousy way to live but it beats being all-the-way dead. Maybe if I make it 20 years they'll...
MRI bill question
May 15, 2013 Dear PFers, The hospital gave us a $12k bill for one MRI (head with contrast). The people I talked to at the hospital tell me that they do not...
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013 As an experiment, for the past few months I've been consuming at least one portion of Jell-O or unflavored Knox gelatin per day. I'm 64, in very...
Alcohol and acetaminophen
May 13, 2013 Edit: sorry for the typo in the title , can't edit I looked around on google quite a bit and it's very hard to find precise information on the...
- More from Physics Forums - Medical Sciences
More news stories
Trends in Helicobacter pylori (H. pylori) and smoking explain a significant proportion of the decline of intestinal-type noncardia gastric adenocarcinoma (NCGA) incidence in US men between 1978 and 2008, and are estimated ...
Medical research 8 hours ago | not rated yet | 0
Widely available in pharmacies and health stores, phosphatidylserine is a natural food supplement produced from beef, oysters, and soy. Proven to improve cognition and slow memory loss, it's a popular treatment for older ...
Medical research 13 hours ago | 5 / 5 (2) | 0 |
Researchers at Emory University have identified a protein that stimulates a pair of "orphan receptors" found in the brain, solving a long-standing biological puzzle and possibly leading to future treatments for neurological ...
Medical research 13 hours ago | 5 / 5 (1) | 0 |
Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.
Medical research 14 hours ago | 4.5 / 5 (6) | 0 |
Researchers at the University of Illinois at Chicago College of Medicine will study gender differences in how the heart uses and stores fat—its main energy source—and how changes in fat metabolism play ...
Medical research 17 hours ago | not rated yet | 0
(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...
14 hours ago | 4.2 / 5 (5) | 0 |
(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...
12 hours ago | 4.9 / 5 (9) | 0 |
An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.
7 hours ago | 3 / 5 (2) | 0
Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...
8 hours ago | 5 / 5 (3) | 0 |
A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.
9 hours ago | 5 / 5 (1) | 0 |
Researchers at USC have found that a class of pharmaceuticals can both prevent and treat Alzheimer's Disease in mice.
11 hours ago | 5 / 5 (4) | 0 |